LANCRIX

Linagliptin, ≥98%

Catalog No. 001811

Identification
SynonymsBI 1356, Tradjenta, Trajenta
CAS No.668270-12-0
M.F.

C25H28N8O2

M.W.472.54
Technical Data
AppearanceWhite or off-white crystalline powder
Assay≥98% HPLC
SolubilityDMSO
Storage-20℃
ApplicationLinagliptin is a DPP-4 inhibitor developed for treatment of type II diabetes.
Safety Data
Reference

von Websky K, et al. Vasc Health Risk Manag. 2013;9:681-694
Haak T, et al. Int J Clin Pract. 2013 Dec;67(12):1283-93
Gallwitz B, et al. Lancet. 2012 Aug 4;380(9840):475-83
Owens DR, et al. Diabet Med. 2011 Nov;28(11):1352-61

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 001811, Linagliptin, ≥98%, 668270-12-0
*Message
*Code If it’s not clear, please click on the picture to change one.